210 related articles for article (PubMed ID: 26602075)
1. Impact of Preprocedural B-Type Natriuretic Peptide Levels on the Outcomes After Transcatheter Aortic Valve Implantation.
Abramowitz Y; Chakravarty T; Jilaihawi H; Lee C; Cox J; Sharma RP; Mangat G; Cheng W; Makkar RR
Am J Cardiol; 2015 Dec; 116(12):1904-9. PubMed ID: 26602075
[TBL] [Abstract][Full Text] [Related]
2. Impact of B-type natriuretic peptide on short-term clinical outcomes following transcatheter aortic valve implantation.
O'Sullivan CJ; Stortecky S; Heg D; Jüni P; Windecker S; Wenaweser P
EuroIntervention; 2015 Feb; 10(10):e1-8. PubMed ID: 24429160
[TBL] [Abstract][Full Text] [Related]
3. Pro B-type natriuretic peptide plasma value: a new criterion for the prediction of short- and long-term outcomes after transcatheter aortic valve implantation.
López-Otero D; Trillo-Nouche R; Gude F; Cid-Álvarez B; Ocaranza-Sanchez R; Alvarez MS; Lear PV; Gonzalez-Juanatey JR
Int J Cardiol; 2013 Sep; 168(2):1264-8. PubMed ID: 23280329
[TBL] [Abstract][Full Text] [Related]
4. Effect of B-type natriuretic peptides on long-term outcomes after transcatheter aortic valve implantation.
Koskinas KC; O'Sullivan CJ; Heg D; Praz F; Stortecky S; Pilgrim T; Buellesfeld L; Jüni P; Windecker S; Wenaweser P
Am J Cardiol; 2015 Nov; 116(10):1560-5. PubMed ID: 26428025
[TBL] [Abstract][Full Text] [Related]
5. B-type natriuretic peptide is a strong independent predictor of long-term outcome after transcatheter aortic valve implantation.
Gotzmann M; Czauderna A; Aweimer A; Hehnen T; Bösche L; Lind A; Kloppe A; Mügge A; Ewers A
J Heart Valve Dis; 2014 Sep; 23(5):537-44. PubMed ID: 25799701
[TBL] [Abstract][Full Text] [Related]
6. Elevation of B-Type Natriuretic Peptide at Discharge is Associated With 2-Year Mortality After Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis: Insights From a Multicenter Prospective OCEAN-TAVI (Optimized Transcatheter Valvular Intervention-Transcatheter Aortic Valve Implantation) Registry.
Mizutani K; Hara M; Iwata S; Murakami T; Shibata T; Yoshiyama M; Naganuma T; Yamanaka F; Higashimori A; Tada N; Takagi K; Araki M; Ueno H; Tabata M; Shirai S; Watanabe Y; Yamamoto M; Hayashida K
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28710182
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of serial B-type natriuretic peptide measurement in transcatheter aortic valve replacement (from the PARTNER Trial).
O'Neill BP; Guerrero M; Thourani VH; Kodali S; Heldman A; Williams M; Xu K; Pichard A; Mack M; Babaliaros V; Herrmann HC; Webb J; Douglas PS; Leon MB; O'Neill WW
Am J Cardiol; 2015 May; 115(9):1265-72. PubMed ID: 25863422
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of B-type natriuretic peptide to predict outcome of patients treated by transcatheter aortic valve implantation.
Kefer J; Beauloye C; Astarci P; Renkin J; Glineur D; Dekleermaeker A; Vanoverschelde JL
Am J Cardiol; 2010 Dec; 106(12):1782-6. PubMed ID: 21055712
[TBL] [Abstract][Full Text] [Related]
9. Different impact of aortic regurgitation assessed by aortic root angiography after transcatheter aortic valve implantation according to baseline left ventricular ejection fraction and N-terminal pro-B-type natriuretic peptide.
Kaneko H; Hoelschermann F; Schau T; Tambor G; Neuss M; Butter C
Cardiovasc Interv Ther; 2018 Jul; 33(3):232-238. PubMed ID: 28567700
[TBL] [Abstract][Full Text] [Related]
10. Assessment of left ventricular function with tissue Doppler echocardiography and of B-type natriuretic peptide levels in patients undergoing transcatheter aortic valve implantation.
Yüksel IO; Arslan S; Cagirci G; Koklu E; Ureyen CM; Bayar N; Kucukseymen S; Kus G; Guven R
Rev Port Cardiol; 2017 May; 36(5):377-383. PubMed ID: 28495181
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Outcomes of Transcatheter Aortic Valve Implantation in Patients ≥90 Years Versus <90 Years.
Abramowitz Y; Chakravarty T; Jilaihawi H; Kashif M; Zadikany R; Lee C; Matar G; Cheng W; Makkar RR
Am J Cardiol; 2015 Oct; 116(7):1110-5. PubMed ID: 26235927
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Outcomes for Patients With Severe Symptomatic Aortic Stenosis Treated With Transcatheter Aortic Valve Implantation.
Codner P; Orvin K; Assali A; Sharony R; Vaknin-Assa H; Shapira Y; Schwartzenberg S; Bental T; Sagie A; Kornowski R
Am J Cardiol; 2015 Nov; 116(9):1391-8. PubMed ID: 26342515
[TBL] [Abstract][Full Text] [Related]
13. Correlation of brain natriuretic peptide levels in patients with severe aortic stenosis undergoing operative valve replacement or percutaneous transcatheter intervention with clinical, echocardiographic, and hemodynamic factors and prognosis.
Ben-Dor I; Minha S; Barbash IM; Aly O; Dvir D; Deksissa T; Okubagzi P; Torguson R; Lindsay J; Satler LF; Pichard AD; Waksman R
Am J Cardiol; 2013 Aug; 112(4):574-9. PubMed ID: 23683951
[TBL] [Abstract][Full Text] [Related]
14. B-type natriuretic peptide is associated with remodeling and exercise capacity after transcatheter aortic valve replacement for aortic stenosis.
Sato K; Kumar A; Krishnaswamy A; Mick S; Desai MY; Griffin BP; Kapadia SR; Popović ZB
Clin Cardiol; 2019 Feb; 42(2):270-276. PubMed ID: 30565264
[TBL] [Abstract][Full Text] [Related]
15. Meta-Analysis of Impact of Baseline N-TerminalPro-Brain Natriuretic Peptide Levels on SurvivalAfter Transcatheter Aortic Valve Implantation for Aortic Stenosis.
Takagi H; Hari Y; Kawai N; Kuno T; Ando T;
Am J Cardiol; 2019 Mar; 123(5):820-826. PubMed ID: 30587374
[TBL] [Abstract][Full Text] [Related]
16. Elevated growth differentiation factor 15 levels predict outcome in patients undergoing transcatheter aortic valve implantation.
Krau NC; Lünstedt NS; Freitag-Wolf S; Brehm D; Petzina R; Lutter G; Bramlage P; Dempfle A; Frey N; Frank D
Eur J Heart Fail; 2015 Sep; 17(9):945-55. PubMed ID: 26230285
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of plasma B-type natriuretic peptide in the assessment of disease severity and prediction of outcome after aortic valve replacement in patients with severe aortic stenosis.
Iwahashi N; Nakatani S; Umemura S; Kimura K; Kitakaze M
J Am Soc Echocardiogr; 2011 Sep; 24(9):984-91. PubMed ID: 21570253
[TBL] [Abstract][Full Text] [Related]
18. Effect of Pulmonary Hypertension Hemodynamic Presentation on Clinical Outcomes in Patients With Severe Symptomatic Aortic Valve Stenosis Undergoing Transcatheter Aortic Valve Implantation: Insights From the New Proposed Pulmonary Hypertension Classification.
O'Sullivan CJ; Wenaweser P; Ceylan O; Rat-Wirtzler J; Stortecky S; Heg D; Spitzer E; Zanchin T; Praz F; Tüller D; Huber C; Pilgrim T; Nietlispach F; Khattab AA; Carrel T; Meier B; Windecker S; Buellesfeld L
Circ Cardiovasc Interv; 2015 Jul; 8(7):e002358. PubMed ID: 26156149
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Implications of Baseline B-type Natriuretic Peptide in Patients Undergoing Transcatheter Aortic Valve Implantation.
Medranda GA; Salhab K; Schwartz R; Green SJ
Am J Cardiol; 2020 Sep; 130():94-99. PubMed ID: 32665134
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of Patients at Estimated Low, Intermediate, and High Risk Undergoing Transcatheter Aortic Valve Implantation for Aortic Stenosis.
Barbash IM; Finkelstein A; Barsheshet A; Segev A; Steinvil A; Assali A; Ben Gal Y; Vaknin Assa H; Fefer P; Sagie A; Guetta V; Kornowski R
Am J Cardiol; 2015 Dec; 116(12):1916-22. PubMed ID: 26602076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
